Exchange: OTC·Updated 07:53 PM EDT
News
all
press releases
Eloxx Pharmaceuticals, Inc. Loss At -$4.50 Mln In Q2
(RTTNews) - Eloxx Pharmaceuticals, Inc. (ELOX) reported Loss for second quarter of -$4.50 million...
Nasdaq News: Markets
Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update PR Newswire ARLINGTON, Mass., Aug. 12, 2026 Completed underwritten public offering with gross proceeds of...
PR Newswire
Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq
Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq PR Newswire ARLINGTON, Mass., June 8, 2026 ARLINGTON, Mass., June 8, 2026 /PRNewswire...
PR Newswire

Advertisement|Remove ads.